CSIMarket
 

Heartsciences Inc   (NASDAQ: HSCS)

Heartsciences Inc 's

Competitiveness




 

HSCS Sales vs. its Competitors Q4 2026



Comparing the current results to its competitors, Heartsciences Inc reported Revenue decrease in the 4 quarter 2026 year on year by 0 %, despite the revenue increase by the most of its competitors of 7.75 %, recorded in the same quarter.

List of HSCS Competitors





Revenue Growth Comparisons




Net Income Comparison


Heartsciences Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 8.59 %

<<  HSCS Stock Performance Comparisons


Heartsciences Inc 's Comment on Competition and Industry Peers


The medical device industry features rapid technological advancements and intense competition, with a focus on proprietary products. Key competitors include traditional ECG manufacturers such as GE Healthcare Technologies, Inc., Koninklijke Philips N.V., Baxter International, Inc., and Nihon Kohden Corporation. New entrants in the AI-ECG market include Anumana, Inc., as well as companies involved in AI healthcare like Tempus Labs, Inc. and VIZ.ai. These companies are engaged in research and development of products comparable to HeartSciences' AI-ECG algorithms and MyoVista hardware.



*Market share is calculated based on total revenue.





Publicly Traded Peers of Heartsciences Inc




Abbott Laboratories
Share Performance



-15.03%
This Year



Abbott Laboratories
Profile

Abbott Laboratories operates as a diversified healthcare company with a focus on developing and manufacturing a wide range of health-related products, including pharmaceuticals, medical devices, nutritional products, and diagnostic technologies. Their business model emphasizes innovation and quality, aiming to address the diverse needs of patients and healthcare providers across various sectors globally. By leveraging their expertise and extensive portfolio, Abbott strives to enhance patient outcomes and improve the overall quality of life.

More about Abbott Laboratories's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 184,351.143 mill. $ 45,134.000 mill. $ 6,276.000 mill.


Carecloud Inc
Share Performance



-39.04%
One Year



Carecloud Inc
Profile

CareCloud Inc is a healthcare technology company that provides cloud-based solutions for medical practices. Their business model revolves around offering a comprehensive platform that integrates electronic health records (EHR), practice management systems, and revenue cycle management tools. By streamlining administrative tasks, improving patient engagement, and optimizing financial performance, CareCloud aims to enhance the efficiency and profitability of medical practices.

More about Carecloud Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 92.211 mill. $ 128.640 mill. $ 7.992 mill.


Irhythm Holdings Inc
Share Performance



+13.87%
This Quarter



Irhythm Holdings Inc
Profile

Irhythm Technologies Inc is a healthcare company that focuses on providing remote cardiac monitoring solutions. Their business model revolves around offering wearable devices that continuously monitor heart rhythms, combined with cloud-based data analysis. They generate revenue by selling and leasing their devices, as well as providing analysis services and data reports to healthcare professionals.

More about Irhythm Holdings Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 4,021.085 mill. $ 825.702 mill. $ -13.947 mill.


Lifestance Health Group Inc
Share Performance



+83.91%
This Year



Lifestance Health Group Inc
Profile

Lifestance Health Group Inc is a mental health care company that provides comprehensive outpatient services. Their business model focuses on delivering personalized, evidence-based treatments to individuals struggling with various mental health conditions. They aim to optimize patient outcomes by employing a collaborative, integrated approach that combines therapy, medication management, and innovative technology solutions.

More about Lifestance Health Group Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 4,957.427 mill. $ 1,584.834 mill. $ 50.600 mill.


Masimo Corp
Share Performance



+41.25%
This Year



Masimo Corp
Profile

Masimo Corp is a medical technology company that focuses on developing and manufacturing innovative monitoring devices for patient care. Their business model revolves around creating and selling advanced noninvasive monitoring solutions to healthcare providers worldwide. They also generate revenue through licensing agreements, providing maintenance and support services, and selling disposable products and accessories related to their monitoring devices.

More about Masimo Corp's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 9,465.370 mill. $ 1,557.000 mill. $ 76.300 mill.

3 more competitors available

Sign in to see all competitors

Sources: Heartsciences Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Heartsciences Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.